PMID- 32846225 OWN - NLM STAT- MEDLINE DCOM- 20210701 LR - 20211216 IS - 1873-0442 (Electronic) IS - 1477-8939 (Linking) VI - 38 DP - 2020 Nov-Dec TI - Clinical aspects of heat-labile and heat-stable toxin-producing enterotoxigenic Escherichia coli: A prospective study among Finnish travellers. PG - 101855 LID - S1477-8939(20)30351-3 [pii] LID - 10.1016/j.tmaid.2020.101855 [doi] AB - BACKGROUND: Enterotoxigenic Escherichia coli (ETEC) is a major pathogen causing travellers' diarrhoea (TD) among visitors to low- and middle-income countries (LMIC). Scant data are available on rates of travel-acquired ETEC producing heat-labile (LT) and/or heat-stable (ST) toxin or its subtypes, STh (human) and STp (porcine) in various geographic regions, and on clinical pictures associated with each toxin. METHODS: Using qPCR, we analysed LT, STh, and STp in stools positive for ETEC in a prospective study among 103 Finnish travellers visiting LMIC. They filled in questionnaires and provided stool samples before and after travel. We scrutinized geographic distribution of LT, STh, and STp ETEC findings, and association between these different ETEC subtypes and moderate/severe TD. RESULTS: Among the 103 stool samples positive for ETEC toxins, the rate for LT was 76%, for STh 26%, and STp 41%. The rate for LT-only was 44%, for STh-only 6%, STp-only 16%, LT + STh 10%, LT + STp 15%, STh + STp 3%, and LT + STh + STp 8%. Findings varied by destination; the rates of LT, STh, and STp were 79%, 21%, and 57%, respectively, in Southern Asia (n = 14); 85%, 10%, and 20% in South-eastern Asia (n = 20); 84%, 13%, and 29% in Eastern Africa (n = 31); and 56%, 50%, and 63% in Western Africa (n = 32), respectively. Of travellers positive for LT, STh, and STp, 83%, 100%, and 88%, encountered TD; 35%, 55%, and 41% reported moderate/severe TD. STh was associated with moderate/severe TD. CONCLUSIONS: Toxin findings varied by destination; multiple toxins were commonly detected. Moderate/severe TD was reported most frequently by subjects with STh-ETEC. CI - Copyright (c) 2020 The Authors. Published by Elsevier Ltd.. All rights reserved. FAU - Turunen, Katri AU - Turunen K AD - Department of Bacteriology and Immunology, University of Helsinki, P.O. Box 21, FI-00014, University of Helsinki, Finland; Inflammation Center, Division of Infectious Diseases, University of Helsinki and Helsinki University Hospital, P.O. Box 348, FI-00029, HUS, Finland. Electronic address: katri.a.turunen@helsinki.fi. FAU - Antikainen, Jenni AU - Antikainen J AD - HUS Diagnostic Center (HUSLAB), Bacteriology, Helsinki, Finland. Electronic address: jenni.antikainen@hus.fi. FAU - Laaveri, Tinja AU - Laaveri T AD - Inflammation Center, Division of Infectious Diseases, University of Helsinki and Helsinki University Hospital, P.O. Box 348, FI-00029, HUS, Finland. Electronic address: tinja.laaveri@hus.fi. FAU - Kirveskari, Juha AU - Kirveskari J AD - HUS Diagnostic Center (HUSLAB), Bacteriology, Helsinki, Finland; Mobidiag Ltd, Helsinki, Finland. Electronic address: juha.kirveskari@mobidiag.com. FAU - Svennerholm, Ann-Mari AU - Svennerholm AM AD - University of Gothenburg, Gothenburg, Sweden. Electronic address: ann-mari.svennerholm@microbio.gu.se. FAU - Kantele, Anu AU - Kantele A AD - Inflammation Center, Division of Infectious Diseases, University of Helsinki and Helsinki University Hospital, P.O. Box 348, FI-00029, HUS, Finland; Travel Clinic, Aava Medical Center, Annankatu 32, FI-00100, Helsinki, Finland. Electronic address: anu.kantele@hus.fi. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200823 PL - Netherlands TA - Travel Med Infect Dis JT - Travel medicine and infectious disease JID - 101230758 RN - 0 (Bacterial Toxins) RN - 0 (DNA, Bacterial) RN - 0 (Enterotoxins) RN - 0 (Escherichia coli Proteins) RN - 0 (heat stable toxin (E coli)) RN - D9K3SN2LNY (heat-labile enterotoxin, E coli) SB - IM MH - Adolescent MH - Adult MH - Africa, Eastern MH - Africa, Western MH - Aged MH - Asia MH - Bacterial Toxins/*genetics MH - Child MH - Child, Preschool MH - DNA, Bacterial MH - Diarrhea/*microbiology MH - Enterotoxigenic Escherichia coli/*genetics/isolation & purification MH - Enterotoxins/*genetics MH - Escherichia coli Infections/*epidemiology MH - Escherichia coli Proteins/*genetics MH - Feces/microbiology MH - Finland MH - Humans MH - Infant MH - Infant, Newborn MH - Middle Aged MH - Prospective Studies MH - Real-Time Polymerase Chain Reaction MH - Travel MH - Travel-Related Illness MH - Young Adult OTO - NOTNLM OT - ETEC OT - LT OT - ST OT - STh OT - STp OT - Travellers' diarrhoea EDAT- 2020/08/28 06:00 MHDA- 2021/07/02 06:00 CRDT- 2020/08/27 06:00 PHST- 2020/02/05 00:00 [received] PHST- 2020/07/28 00:00 [revised] PHST- 2020/08/19 00:00 [accepted] PHST- 2020/08/28 06:00 [pubmed] PHST- 2021/07/02 06:00 [medline] PHST- 2020/08/27 06:00 [entrez] AID - S1477-8939(20)30351-3 [pii] AID - 10.1016/j.tmaid.2020.101855 [doi] PST - ppublish SO - Travel Med Infect Dis. 2020 Nov-Dec;38:101855. doi: 10.1016/j.tmaid.2020.101855. Epub 2020 Aug 23.